Suchergebnisse - "Smith, Terry J"

PubPharm (21)

1

Teprotumumab Divergently Alters Fibrocyte Gene Expression : Implications for Thyroid-associated Ophthalmopathy

enthalten in: The Journal of clinical endocrinology and metabolism | 2022

von Fernando, R. | Smith, T.

2

Understanding Pathogenesis Intersects With Effective Treatment for Thyroid Eye Disease

enthalten in: The Journal of clinical endocrinology and metabolism | 2022

von Smith, T.

ErratumIn: J Clin Endocrinol Metab. 2023 Feb 15;108(3):e46. - PMID 36513816

3

Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment : OPTIC-X Study

enthalten in: Ophthalmology | 2022

von Douglas, R. | Kahaly, G. | Ugradar, S. | +19

4

Therapeutic IGF-I receptor inhibition alters fibrocyte immune phenotype in thyroid-associated ophthalmopathy

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2021

von Fernando, R. | Caldera, O. | Smith, T.

CommentIn: Proc Natl Acad Sci U S A. 2022 Feb 1;119(5):. - PMID 35086933

5

Teprotumumab in Clinical Practice : Recommendations and Considerations From the OPTIC Trial Investigators

enthalten in: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society | 2021

von Douglas, R. | Wang, Y. | Dailey, R. | +7

6

Teprotumumab for patients with active thyroid eye disease : a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials

enthalten in: The lancet. Diabetes & endocrinology | 2021

von Kahaly, G. | Douglas, R. | Holt, R. | +2

CommentIn: Lancet Diabetes Endocrinol. 2021 Jun;9(6):323-325. - PMID 33865499

7

Lessons Learned from Targeting IGF-I Receptor in Thyroid-Associated Ophthalmopathy

enthalten in: Cells | 2021

von Janssen, J. | Smith, T.

8

Teprotumumab for Optic Neuropathy in Thyroid Eye Disease

enthalten in: JAMA ophthalmology | 2021

von Slentz, D. | Smith, T. | Kim, D. | +1

9

Insulin-Like Growth Factor Pathway and the Thyroid

enthalten in: Frontiers in endocrinology | 2021

von Smith, T.

10

Teprotumumab : a novel therapeutic monoclonal antibody for thyroid-associated ophthalmopathy

enthalten in: Expert opinion on investigational drugs | 2020

von Slentz, D. | Nelson, C. | Smith, T.